Protect Financial Statements From 2010 to 2024
| PRTT Stock | USD 0.78 0.01 1.27% |
Check Protect Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protect Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Protect financial statements analysis is a perfect complement when working with Protect Pharmaceutical Valuation or Volatility modules.
Protect |
Protect Pharmaceutical Company Current Valuation Analysis
Protect Pharmaceutical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Protect Pharmaceutical Current Valuation | 2.6 M |
Most of Protect Pharmaceutical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Protect Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Protect Pharmaceutical has a Current Valuation of 2.6 M. This is 99.96% lower than that of the Pharmaceuticals sector and 99.92% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.98% higher than that of the company.
Protect Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Protect Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Protect Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Protect Pharmaceutical competition to find correlations between indicators driving Protect Pharmaceutical's intrinsic value. More Info.Protect Pharmaceutical is rated below average in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 0.43 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Protect Pharmaceutical is roughly 2.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Protect Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Protect Pharmaceutical Financial Statements
Protect Pharmaceutical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Protect Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in Protect Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Protect Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada. Protect Pharmaceutical is traded on OTC Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.